The CiRA Foundation®, Center for iPS Cell Research and Application, Kyoto University, Kyoto University Hospital and Rinku General Medical Center have been working to promote research on COVID-19.

We have started accepting applications for the free provision of induced pluripotent stem (iPS) cells made from the blood samples of COVID-19 convalescent patients on March 25, 2021. The establishment of iPS cells from three patients has already begun.
Please click here to see the related press release.

Now, we are pleased to announce that we have prepared iPS cells made from blood samples of three more COVID-19 convalescent patients.
In total, 15 iPS cell clones made from 6 patients are available for research purposes.

The Foundation will continue to provide quality-assured iPS cells to research institutes and companies to contribute to new diagnostic and therapeutic methods for COVID-19.

Click here for more information.